IN THIS ISSUE

John Carroll
Medical directors have been hard-pressed to come to a consensus on just how — or whether — this new wrinkle in the managed care business fits in.
Peer-Reviewed
Jaan Sidorov, MD
What went wrong between Penn State and Geisinger, and what lessons should be learned?
Legislation & Regulation
John Carroll
Health plans can expect to pay less in dues, but whether the new organization will have increased influence with legislators remains to be seen.
Ethics
Michael S. Victoroff, MD
A program to reduce medical errors promised providers that confidentiality would be protected. Then came a problem demanding immediate attention.
Tomorrow's Medicine
Thomas Morrow, MD
Treatments that interfere with protein synthesis at the cellular level will soon be debated in medical policy committee meetings.
News and Commentary